109 related articles for article (PubMed ID: 27579554)
1. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry.
Hoppe BS; Tsai H; Larson G; Laramore GE; Vargas C; Tseng YD; Dunn M; McGee L; Cahlon O; Hartsell W
Acta Oncol; 2016 Nov; 55(11):1378-1380. PubMed ID: 27579554
[No Abstract] [Full Text] [Related]
2. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
[TBL] [Abstract][Full Text] [Related]
3. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
4. [Results of combined therapy for lymphogranulomatosis in children].
Kolygin BA; Lebedev SV; Borodina AF; Kochurova NV; Malinin AP; Safonova SA; Punanov IuA
Vopr Onkol; 2000; 46(2):232-5. PubMed ID: 10853430
[No Abstract] [Full Text] [Related]
5. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
6. [Effectiveness of various combinations of chemoradiotherapy for children and adolescents with Hodgkin's disease].
Parkhomenko RA; Shcherbenko OI; Zelinskaia NI; Rodionov MV; Abbasova EV; Ardatova GV; Khalil' EF; Sycheva NA; Skvortsova OIu
Vopr Onkol; 2009; 55(4):480-2. PubMed ID: 19947376
[TBL] [Abstract][Full Text] [Related]
7. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
[TBL] [Abstract][Full Text] [Related]
8. Proton therapy for Hodgkin lymphoma.
Rutenberg MS; Flampouri S; Hoppe BS
Curr Hematol Malig Rep; 2014 Sep; 9(3):203-11. PubMed ID: 24842407
[TBL] [Abstract][Full Text] [Related]
9. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma.
Holtzman A; Flampouri S; Li Z; Mendenhall NP; Hoppe BS
Acta Oncol; 2013 Apr; 52(3):592-4. PubMed ID: 23477362
[No Abstract] [Full Text] [Related]
10. Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience.
Loap P; Goudjil F; Dendale R; Kirova Y
Cancer Radiother; 2021 Dec; 25(8):779-785. PubMed ID: 34275748
[TBL] [Abstract][Full Text] [Related]
11. Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.
Specht L
Cancer Treat Rev; 2004 Aug; 30(5):479-82. PubMed ID: 15245780
[No Abstract] [Full Text] [Related]
12. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
[TBL] [Abstract][Full Text] [Related]
13. Patterns of subsequent malignancies after Hodgkin lymphoma in children and adults.
Omer B; Kadan-Lottick NS; Roberts KB; Wang R; Demsky C; Kupfer GM; Cooper D; Seropian S; Ma X
Br J Haematol; 2012 Sep; 158(5):615-25. PubMed ID: 22775513
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma.
Nanda R; Flampouri S; Mendenhall NP; Indelicato DJ; Jones LM; Seeram VK; Hoppe BS
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):494-497. PubMed ID: 28872001
[No Abstract] [Full Text] [Related]
15. Increased relapse rates in early stage hodgkin lymphoma (HL) patients without radiotherapy: the German Society of Radiooncology (DEGRO) advises to treat all early stage HL patients with radiotherapy.
Körholz D; Mauz-Körholz C; Vordermark D; Kluge R; Dieckmann K
Klin Padiatr; 2014 Nov; 226(6-7):307-8. PubMed ID: 25431863
[No Abstract] [Full Text] [Related]
16. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
17. Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister TA; Radford JA; Rohatiner AZ; Linch DC
J Clin Oncol; 2011 Nov; 29(31):4096-104. PubMed ID: 21969511
[TBL] [Abstract][Full Text] [Related]
18. Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
Torok JA; Wu Y; Prosnitz LR; Kim GJ; Beaven AW; Diehl LF; Kelsey CR
Int J Radiat Oncol Biol Phys; 2015 May; 92(1):54-9. PubMed ID: 25863754
[TBL] [Abstract][Full Text] [Related]
19. Vinblastine, bleomycin, and methotrexate chemotherapy plus irradiation for patients with early-stage, favorable Hodgkin lymphoma: the experience of the Gruppo Italiano Studio Linfomi.
Gobbi PG; Broglia C; Merli F; Dell'Olio M; Stelitano C; Iannitto E; Federico M; Bertè R; Luisi D; Molica S; Cavalli C; Dezza L; Ascari E
Cancer; 2003 Dec; 98(11):2393-401. PubMed ID: 14635074
[TBL] [Abstract][Full Text] [Related]
20. [Combination chemotherapy in malignant lymphoma. Results of long-term follow-up].
Kimura I; Ohnoshi T; Ueoka H; Nishihara R
Rinsho Ketsueki; 1985 Jun; 26(6):831-40. PubMed ID: 4068248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
